PharmaMatrix Holdings Ltd

1 clinical trials · Sponsor

Record	Firm	Date
A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours (NCT04823897)	PharmaMatrix Holdings Ltd	2021-07-26

Every clearance here is in the API, with alerts when new ones post.